Radiation therapy in the management of head-and-neck cancer of unknown primary origin: How does the addition of concurrent chemotherapy affect the therapeutic ratio?

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 2, 2011, Pages 346-352

  Chen, Allen M ^a   Farwell, D Gregory ^a   Lau, Derick H ^a   Li, Bao Qing ^a   Luu, Quang ^a   Donald, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervical lymph node metastasis; Chemoradiation; Head and neck cancer; Radiation therapy; Unknown primary

Indexed keywords

BODY FLUIDS; CHEMORADIOTHERAPY; CHEMOTHERAPY; CONCURRENCY CONTROL; DISEASES; PATHOLOGY; PATIENT MONITORING; RADIATION; TOXICITY;

CERVICAL LYMPH NODES; CHEMO RADIATIONS; CONCURRENT CHEMORADIATION; HEAD-AND-NECK CANCER; INTENSITY-MODULATED RADIOTHERAPY; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS; UNKNOWN PRIMARRIES;

RADIOTHERAPY;

CISPLATIN;

ACUTE TOXICITY; ADULT; AGED; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER OF UNKNOWN PRIMARY SITE; CANCER SURGERY; CHEMORADIOTHERAPY; DYSPHAGIA; ESOPHAGITIS; ESOPHAGUS DISEASE; ESOPHAGUS STRICTURE; FEMALE; HEAD AND NECK CARCINOMA; HOARSENESS; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; LARYNX EDEMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; OTITIS MEDIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; REVIEW; SKIN EXFOLIATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 80052809800     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.031     Document Type: Article

References (27)

1. C. Grau, L.V. Johansen, and J. Jakobsen Cervical lymph node metastases from unknown primary tumours: Results from a national survey by the Danish Society for Head and Neck Oncology Radiother Oncol 55 2000 121 129 (Pubitemid 30229986)
2. K. Sinnathamby, L.J. Peters, and C. Laidlaw The occult head and neck primary: To treat or not to treat? Clin Oncol 9 1997 322 329 (Pubitemid 27480632)
3. J.L. Lefebvre, B. Coche-Dequeant, and J. Ton Van Cervical lymph nodes from an unknown primary tumor in 190 patients Am J Surg 160 1990 443 446 (Pubitemid 20346340)
4. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III trial comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
5. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
6. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952 (Pubitemid 38580197)
7. B. Jeremic, Y. Shibamoto, and B. Milicic Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial J Clin Oncol 18 2000 1458 1464 (Pubitemid 30205391)
8. National Comprehensive Cancer Network. The NCCN head andneck cancers clinical practice guidelines in oncology (Version 1.2009). Available at: http://www.nccn.org. Accessed on December 1, 2009.
9. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
10. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 547 581
11. J.P. Pignon, A. Le Maitre, and E. Maillard Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomized trials and 17,346 patients Radiother Oncol 92 2009 4 14
12. K.E. Rusthoven, M. Koshy, and A.C. Paulino The role of flurodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor Cancer 101 2004 2641 2649 (Pubitemid 39532297)
13. R. Dickson, and D.R. Vargas Occult primary of the head and neck J Otolaryngol 8 1979 427 434 (Pubitemid 10209929)
14. L.H. Schwartz, M. Ozsahin, and G.N. Zhang Synchronous and metachronous head and neck carcinomas Cancer 74 1994 1933 1938 (Pubitemid 24301857)
15. F. De Braud, L.K. Heilbrun, and K. Ahmed Metastatic squamous cell carcinoma of an unknown primary localized to the neck: Advantages of an aggressive treatment Cancer 64 1989 510 515 (Pubitemid 19180415)
16. B. Jeremic, L. Ziviz, and S. Jevremovic Radiotherapy and cisplatin in metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck. A Phase II study J Chemother 1992 399 402 (Pubitemid 23030548)
17. A. Argiris, S.M. Smith, and K. Stenson Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary Ann Oncol 13 2003 1306 1311 (Pubitemid 37039060)
18. N.J. Shehadeh, J.F. Ensley, and O. Kucuk Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck Head Neck 28 2006 1090 1098 (Pubitemid 44871518)
19. H. Christiansen, R.M. Hermann, and A. Martin Neck lymph node metastases from an unknown primary tumor Strahlenther Onkol 181 2005 355 362
20. J.J. Caudell, P.E. Schaner, and R.F. Meredith Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 73 2009 410 415
21. M. Machtay, J. Moughan, and A. Trotti Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis J Clin Oncol 26 2008 3582 3589
22. K.M. Greven, D.R. White, and J.D. Browne Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma Am J Clin Oncol 31 2008 209 212
23. S.A. McCloskey, W. Jaggernauth, and N.R. Rigual Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck Am J Clin Oncol 32 2009 587 591
24. F.Y. Feng, H.M. Kim, and T.H. Lyden Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures Int J Radiat Oncol Biol Phys 68 2007 1289 1298 (Pubitemid 47176817)
25. A.S. Garden, W.H. Morrison, and P.F. Wong et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 67 2007 438 444 (Pubitemid 46108322)
26. C. Nieder, V. Gregoire, and K.K. Ang Cervical lymph node metastasis from occult squamous cell carcinoma: Cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 50 2001 727 733 (Pubitemid 32515327)
27. H. Lu, M. Yao, and H. Tan Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: To what extent the volume should be irradiated Oral Oncol 45 2009 474 479